In the Driver’s Seat With EGFR: Application of Mutation Testing to Treatment Selection for NSCLC Lung 1 Min Read0 With over 55% of cancer patients treated by community oncologists, it’s imperative that community oncologists and pathologists apply a multidisciplinary…
